Chronic myeloid leukemia interventions

Full Name

Leukemia (CA 180-330): Studying interventions for managing patients with chronic myeloid leukemia in chronic phase: the 5-year prospective cohort study (SIMPLICITY) (2_PRO00000118)

Description

Information about participants' CP-CML disease, medical history, treatments for CP-CML, and health status will be collected and evaluated with other similar patients and their treatments. Participants must complete 5 questionnaires (either on paper or online on a confidential study website). The data collected during this study will help to improve knowledge and understanding the treatments that work best to treat CP-CML.

Eligibility

Inclusion Criteria

o Newly-diagnosed CP-CML patients who started their first-line TKI treatment on imatinib, dasatinib or nilotinib in accordance with protocol timelines
o 18 years or older at the time of CP-CML diagnosis
o Receiving treatment at medical practice
o Cannot be participating in an interventional trial which influences disease management of the CP-CML